Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

Lars Forsberg, Jan Dumanski and colleagues report that age-related loss of chromosome Y in peripheral blood is associated with increased risks of all-cause mortality, cancer mortality and non-hematological cancer mortality. Incidence and mortality for sex-unspecific cancers are higher among men, a f...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 46; no. 6; pp. 624 - 628
Main Authors Forsberg, Lars A, Rasi, Chiara, Malmqvist, Niklas, Davies, Hanna, Pasupulati, Saichand, Pakalapati, Geeta, Sandgren, Johanna, de Ståhl, Teresita Diaz, Zaghlool, Ammar, Giedraitis, Vilmantas, Lannfelt, Lars, Score, Joannah, Cross, Nicholas C P, Absher, Devin, Janson, Eva Tiensuu, Lindgren, Cecilia M, Morris, Andrew P, Ingelsson, Erik, Lind, Lars, Dumanski, Jan P
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.06.2014
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Lars Forsberg, Jan Dumanski and colleagues report that age-related loss of chromosome Y in peripheral blood is associated with increased risks of all-cause mortality, cancer mortality and non-hematological cancer mortality. Incidence and mortality for sex-unspecific cancers are higher among men, a fact that is largely unexplained 1 , 2 . Furthermore, age-related loss of chromosome Y (LOY) is frequent in normal hematopoietic cells 3 , 4 , but the phenotypic consequences of LOY have been elusive 5 , 6 , 7 , 8 , 9 , 10 . From analysis of 1,153 elderly men, we report that LOY in peripheral blood was associated with risks of all-cause mortality (hazards ratio (HR) = 1.91, 95% confidence interval (CI) = 1.17–3.13; 637 events) and non-hematological cancer mortality (HR = 3.62, 95% CI = 1.56–8.41; 132 events). LOY affected at least 8.2% of the subjects in this cohort, and median survival times among men with LOY were 5.5 years shorter. Association of LOY with risk of all-cause mortality was validated in an independent cohort (HR = 3.66) in which 20.5% of subjects showed LOY. These results illustrate the impact of post-zygotic mosaicism on disease risk, could explain why males are more frequently affected by cancer and suggest that chromosome Y is important in processes beyond sex determination. LOY in blood could become a predictive biomarker of male carcinogenesis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.2966